NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation
Clinical trial NCT03396068 · UNKNOWN
Trial details
- NCT number
- NCT03396068
- Sponsor
- NeuroRx, Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2024-12-31
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.